A new approach targets the B-cell pathway with bispecific antibodies, building on decades of research that establishes the ...
A study led by the Peter Doherty Institute for Infection and Immunity found there is a worrying increase in strep bacteria growing at rapidly different rates in different parts of the country. The ...
The Phase 3 ADAPT SERON study met its primary endpoint (p-value=0.0068), demonstrating that AChR-Ab seronegative gMG patients treated with VYVGART achieved a statistically significant improvement in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback